National Taiwan University Hospital ( Site 3100)

Taipei 10002

0 studies enrolling now · 5 studies all time

What they study most

Arteriosclerosis, Coronavirus Disease (COVID-19), Familial Hypercholesterolemia, Hypercholesterolaemia, Hypercholesterolemia

Studies at this site

• A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-013) CORALreef Lipids — Completed
• Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes — Running, not enrolling
• A Study of Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) in Adults With Heterozygous Familial Hypercholesterolemia (MK-0616-017/CORALreef HeFH) — Completed
• Open-label Extension Study of Enlicitide Decanoate (MK-0616/Enlicitide Oral PCSK9 Inhibitor) in Adults With Hypercholesterolemia (MK-0616-019) CORALreef Extension — Running, not enrolling
• Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002) — Completed